The SHELTER Trial of Transplanting Hepatitis C Virus–Infected Lungs Into Uninfected Recipients

SHELTER is a trial of transplanting lungs from deceased donors with hepatitis C virus (HCV) infection into HCV-negative candidates (sponsor: Merck; NCT03724149). Few trials have reported outcomes using thoracic organs from HCV-RNA(+) donors and none have reported quality of life (QOL). METHODS. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Reese, Peter P., Diamond, Joshua M., Goldberg, David S., Potluri, Vishnu, Prenner, Stacey, Blumberg, Emily A., Van Deerlin, Vivianna M., Reddy, K. Rajender, Mentch, Heather, Hasz, Richard, Woodards, Ashley, Gentile, Caren, Smith, Jennifer, Bermudez, Christian, Crespo, Maria M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Lung Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306429/
https://www.ncbi.nlm.nih.gov/pubmed/37389016
http://dx.doi.org/10.1097/TXD.0000000000001504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306429/
https://www.ncbi.nlm.nih.gov/pubmed/37389016
http://dx.doi.org/10.1097/TXD.0000000000001504

Ejemplares similares